peripheral blood mononuclear cells / PBMCs; peripheral blood samples
-
immune regulation (other); ceRNA regulation (other); other pathway/process (other); m6A modification (other); mRNA stability (other)
Microarray; RNase R Treatment; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis
Potential tool for differentiating and diagnosing FT1D.
hsa_circRNA_038288 was down-regulated in PBMCs from FT1D patients compared with T1D patients and was validated by RT-qPCR. The study predicts that it participates in diabetes- and immune regulation-related circRNA-miRNA-mRNA networks, especially a possible hsa_circRNA_038288-hsa-miR-320a-NFAT5 axis, and may also have protein-coding potential.
0.5135
Differences in Immune Cell-Derived Circular RNA Between Fulminant Type 1 Diabetes and Type 1 Diabetes.
combined biological and clinical study